Carlton Haywood Jr.
Carlton Haywood Jr., PhD, MA, is a core faculty member at the Johns Hopkins Berman Institute of Bioethics, associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research, and an assistant professor in the Division of Hematology at the Johns Hopkins School of Medicine. Dr. Haywood recently received his doctorate in bioethics and health policy from the Johns Hopkins Bloomberg School of Public Health. Dr. Haywood received his undergraduate degree in religious studies (1999), and his master’s degree in bioethics (2003), from the University of Virginia. Dr. Haywood conducts empirical bioethics and health services research related to sickle cell disease. Additionally, Dr. Haywood is interested in the articulation of African American perspectives in bioethics. Dr. Haywood’s dissertation examined the association of patient-centered care with trust in the medical profession among adults with sickle cell disease. Dr. Haywood currently has a career development award (K01) from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes for Health (NIH) to continue his studies of trust among sickle cell patients. Dr. Haywood’s dissertation and doctoral training were also funded by the NHLBI through a National Research Service Award. Dr. Haywood’s professional activities include involvement in sickle cell initiatives at the state and federal level. Dr. Haywood serves on Maryland’s Statewide Steering Committee on Services for Adults with Sickle Cell Disease. At the federal level, Dr. Haywood serves on a National Human Genome Research Institute sponsored working group charged with examining the evidence regarding the clinical implications of sickle cell carrier status. Dr. Haywood also serves as a member of the oversight steering committee for the Health Resources and Services Administration’s Sickle Cell Disease Treatment Demonstration Program.
BA, University of Virginia
MA, University of Virginia
PhD, Johns Hopkins University
1: Elander J, Beach MC, Haywood C Jr. Respect, trust, and the management of
sickle cell disease pain in hospital: comparative analysis of concern-raising
behaviors, preliminary model, and agenda for international collaborative research
to inform practice. Ethn Health. 2011 Aug-Oct;16(4-5):405-21. PubMed PMID:
21797726; PubMed Central PMCID: PMC3233840.
2: Dampier C, Haywood C Jr, Lantos J. A “narcotics contract” for a patient with
sickle cell disease and chronic pain. Pediatrics. 2011 Jul;128(1):127-31. Epub
2011 Jun 20. PubMed PMID: 21690122.
3: Carroll CP, Haywood C Jr, Lanzkron S. Prediction of onset and course of high
hospital utilization in sickle cell disease. J Hosp Med. 2011 May;6(5):248-55.
doi: 10.1002/jhm.850. PubMed PMID: 21661098.
4: Butrick M, Roter D, Kaphingst K, Erby LH, Haywood C Jr, Beach MC, Levy HP.
Patient reactions to personalized medicine vignettes: an experimental design.
Genet Med. 2011 May;13(5):421-8. PubMed PMID: 21270639; PubMed Central PMCID:
5: Haywood C Jr, Lanzkron S, Hughes MT, Brown R, Massa M, Ratanawongsa N, Beach
MC. A video-intervention to improve clinician attitudes toward patients with
sickle cell disease: the results of a randomized experiment. J Gen Intern Med.
2011 May;26(5):518-23. Epub 2010 Dec 23. PubMed PMID: 21181560; PubMed Central
PMCID: PMC3077483. http://www.ncbi.nlm.nih.gov/pubmed/21181560
6: Haywood C Jr, Beach MC, Bediako S, Carroll CP, Lattimer L, Jarrett D, Lanzkron
S. Examining the characteristics and beliefs of hydroxyurea users and nonusers
among adults with sickle cell disease. Am J Hematol. 2011 Jan;86(1):85-7. PubMed
PMID: 21117058; PubMed Central PMCID: PMC3233349.